We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Health Canada has provided positive feedback on Tetra Bio-Pharma’s clinical trial application to evaluate its drug candidate ARDS-003 in Covid-19 patients.
Tetra Bio-Pharma will be requesting a meeting with the U.S. Food and Drug Administration (FDA) to discuss the drug development program for its Orphan Drug candidate HCC011 ...